Does creatine help in perimenopause?
Possibly, if you lift weights. Creatine plus strength training adds a little muscle and strength in women past menopause, and falling hormones can speed up muscle loss in the years before it. For brain fog, sleep and hot flashes, there are two small trials with early hints, and the brain-fog question is still open.
If you take creatine, our pick is BulkSupplements: $0.17 a dose, about $5.16 a month, with a lab test and an NSF listing.
Plenty of research after menopause. Very little before it.

Why your feed is full of it
Creatine used to be a supplement for men at the gym. Now women are some of its biggest buyers, and a 2025 review from a lab that studies creatine in women made the case for using it through the change.*1
The pitch goes like this. As estrogen and other hormones fall, women lose muscle and strength faster. Creatine helps muscle, and it also feeds the brain’s energy supply. So it might help with the muscle loss, the tiredness, the brain fog and the mood swings too.*1 The review frames each of these as something creatine may do. The question is which of them has been tested.
What has a track record: muscle, with weights
The best evidence comes from women past menopause, average age about 62. A 2026 review looked at 7 trials with 608 women. In the trials that measured lean mass (5 trials, 338 women), creatine added about 0.37 kg compared with placebo. On the leg press (3 trials, 111 women), it added about 7.5 kg. The gains showed up in trials that used about 5 grams a day or more along with strength training. Bone density did not change, and the review calls the evidence small and mixed.*2
Falling hormones can speed up muscle loss, so this is the finding most likely to matter to you now. But no one has tested whether starting creatine during the change protects more muscle than starting later.*1, 2 For more on creatine after menopause, see our guide to creatine for women.
What has been tested in perimenopause
Much less. As recently as 2025, that same lab wrote that, as far as it knew, no study had looked at creatine in women going through perimenopause.*1 The 2026 review found none run during the change itself.*2 We found two small trials since.
Trial 1: 51 women, six weeks of lifting. At the University of North Carolina, researchers split 51 women in perimenopause, average age 46, into three groups. Eighteen took creatine and 20 took a placebo, and both groups lifted weights twice a week for six weeks. The other 13 did not train. The creatine group took 20 grams a day for 5 days, then about 4.5 grams a day. Every day, the women wore a WHOOP fitness wristband and rated their symptoms.*3
| What they measured | Creatine vs placebo |
|---|---|
| Thinking speed (a color-word test) | No difference. Scores improved over time in all groups. |
| Blood oxygen in the front of the brain, during that test | Up slightly with creatine, down on placebo. |
| Sleep consistency at week 6 (a wristband score) | 7.4 points higher with creatine. |
| Days rated “temperature sensitive” | Fewer with creatine. |
| Brain fog, tiredness, soreness, bloating | Tracked every day. The summary gives no result for these. |
Source: Baker et al., 2026 (abstract) · Free to reuse with credit to Fine Print Nutrition
The authors call this an early, exploratory look. More oxygen in the brain during a test is not the same as thinking better, and the thinking scores did not differ. The sleep and symptom numbers came from the wristband and the women’s own ratings. An employee of WHOOP, the wristband maker, ran that analysis without knowing who took what, and the code is public. The senior author advises creatine makers.*3
Trial 2: 36 women, a much smaller dose. In Serbia, 36 women around menopause, average age 50, took one of three low-dose creatine products or a placebo for 8 weeks, roughly 9 women per group. The doses were 750 to 1,500 milligrams a day, a fraction of the usual 5 grams, in a different form, creatine hydrochloride.*4
Against placebo, the 1,500 milligram group came out ahead on reaction time (6.6% better, against 1.2%) and on creatine in the front of the brain (up 16.4%, against 0.9%). Any effect on mood swings was too small to be sure of. The trial included women already past menopause, and its summary describes no exercise program.*4
What no one has tested yet
- Brain fog. One trial tracked it every day, but its summary does not report the result.
- Hot flashes. The one related finding, fewer “temperature sensitive” days, comes from the women’s own daily ratings, not a count of hot flashes.
- Anything longer than 8 weeks. Both perimenopause trials were short.
- Plain creatine without lifting. The larger trial paired it with weight training. The smaller one used a different form at a much lower dose.
How to take it, based on the trials
None of these doses has been tested in perimenopause itself, so this is how the closest trials did it.*2, 3 A plain bag covers it for about $5.16 a month, with no “women’s” markup. More on dosing: how much creatine per day. Our pick: BulkSupplements’ 500 g bag Lab test + NSF Certified for Sport
- The trials used about 5 grams a day. That, or more, is what women took in the trials where they gained muscle and strength. The 1 to 3 gram trials had no exercise program, so dose and training can’t be separated.
- Pair it with strength training. The menopause trials that found gains all paired creatine with strength training, two or three times a week.
- Loading is optional. The UNC trial started with 20 grams a day for 5 days. Without it, 5 grams a day fills your muscles in about 3 to 4 weeks.
- Use plain creatine monohydrate. It is the form the menopause review covered and the UNC trial used. You do not need a “women’s” formula.
- Mention it before a blood test. Creatine can raise creatinine, a kidney marker on blood tests. In the menopause trials, kidney measures did not change.
Our pick
Women in the menopause trials who gained muscle and strength took 5 grams a day of plain creatine monohydrate. This powder passed a SuppCo lab test of its label, carries NSF Certified for Sport, and is the lowest cost per dose we found with both.*5, 6
BulkSupplements Creatine Monohydrate Powder, 500 g
| Lab test | 98.6% of label (SuppCo, June 2025, one sample)*5 |
|---|---|
| Certification | NSF Certified for Sport*6 |
| At 5 g a day | $0.17 a dose, about $5.16 a month |
Why this one. Plain monohydrate is what the trials used, so there is no reason to pay more for a blend or a “women’s” label. It is unflavored, so it mixes into coffee, juice or a smoothie. Our full creatine ranking shows the runners-up.
Prices read on Amazon Nov 20, 2026. Lab results describe the batch tested, not every bag.
Questions people ask
- Does creatine help with perimenopause brain fog?
- Not shown. One trial tracked brain fog every day for six weeks, but its summary does not report the result. Brain oxygen during a thinking test rose with creatine, while thinking scores did not change.*3
- Does creatine help with hot flashes?
- Not shown. In one six-week trial, women on creatine rated fewer days as “temperature sensitive” than women on placebo. That was their own rating, not a count of hot flashes, and it has not been repeated.*3
- How much creatine should I take in perimenopause?
- No trial has compared doses in perimenopause. The UNC trial used 20 g a day for 5 days, then about 4.5 g. In women past menopause, the trials that found gains used about 5 g a day or more, with strength training.*2
The best creatine for women · The evidence for creatine, graded by outcome · Does creatine cause hair loss?
Review log
- Prices and stock checked on Amazon November 20, 2026.
- : Updated. Our pick now shows the 500 g BulkSupplements bag that our Amazon link opens, with its price and cost per dose
- : Published
Notes and sources
- How we built this: we read the 2026 review of menopause trials and the 2025 women’s-health review in full, and the two perimenopause trials as abstracts, because the full papers are paywalled. Every paper was matched to its PubMed record on October 29, 2026. Fine Print ran no tests of its own, and none of us is a doctor.
- “2 trials, 87 women” adds the 51 women in the UNC trial and the 36 in the Serbian trial; some of the 36 were already past menopause. In the chart, 1 dot is 10 women, rounded.
- Photos are illustrations. Charts and the data file are free to reuse with credit to Fine Print Nutrition.
- Smith-Ryan AE et al. Creatine in women’s health: bridging the gap from menstruation through pregnancy to menopause. J Int Soc Sports Nutr 2025. PMID 40371844. Authors advise Alzchem and Create Wellness.
- Naddafha S, Antonio J, Kreider RB, Stout JR. Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis. J Int Soc Sports Nutr 2026. PMID 42141930. Kreider chairs an advisory board supported by Alzchem, a creatine maker; Alzchem paid part of the publication fee.
- Baker PA et al. Creatine supplementation effects on cognition, sleep, and menopause symptoms in response to six weeks of high-intensity resistance training in perimenopausal females. Eur J Appl Physiol 2026. PMID 42926218. We read the abstract; the full paper is paywalled. The senior author advises creatine makers and holds equity in Create Wellness; a WHOOP employee ran the sleep and symptom analysis.
- Korovljev D et al. The effects of 8-week creatine hydrochloride and creatine ethyl ester supplementation on cognition, clinical outcomes, and brain creatine levels in perimenopausal and menopausal women (CONCRET-MENOPA). J Am Nutr Assoc 2026. PMID 40854087. We read the abstract; the full paper is paywalled.
- SuppCo. Tested: creatine. June 12, 2025. Lab not named; one sample per product.
- NSF Certified for Sport listing 1796571: BulkSupplements creatine monohydrate.